Netpharm Consulting ApS: Financial statements 2023
CVR: 41104554
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Netpharm Consulting ApS (CVR 41104554) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -19,807 and a net result of DKK -19,807 compared with DKK -10,057 the year before. Equity in the 2023 report amounted to DKK 47,994. The solvency ratio was 100%.
- Gross Profit
- DKK -19,807
- Profit/Loss
- DKK -19,807
- Equity
- DKK 47,994
- Total Assets
- DKK 47,994
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -20K | -20K | 48K | - |
| 2022 | - | - | -10K | 68K | - |
| 2021 | 153K | 200 | 200 | 78K | - |
| 2020 | 0 | -12K | -12K | 28K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Netpharm Consulting ApS has published its annual report for 2022. The net result was DKK -10,057.
About Netpharm Consulting ApS
Netpharm Consulting ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Byong Sandersen. The company is owned by Netpharm Holding ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,341 and a net result of DKK -18,341 compared with DKK -14,288 the year before. Equity in the 2025 report amounted to DKK 15,365.